Therapy of Malignant Brain Tumours

Por Rampling, R
Publicado em 1987

Combined modality therapy of central nervous system tumours

Por Rampling, R
Publicado em 2001

THE PRESENT AND FUTURE MANAGEMENT OF MALIGNANT BRAIN TUMOURS: SURGERY, RADIOTHERAPY, CHEMOTHERAPY

Por Rampling, R, James, A, Papanastassiou, V
Publicado em 2004

Fast neutron treatment as an alternative to radical surgery for malignant tumours of the facial area.

Por Catterall, M, Blake, P R, Rampling, R P
Publicado em 1984

rhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU.

Por Rampling, R., Steward, W., Paul, J., Macham, M. A., Harvey, E., Eckley, D.
Publicado em 1994

Malignant cerebral glioma. Modern radiotherapy can give good quality survival for six months.

Por Brada, M., Thomas, D., Rampling, R., Crawford, P., Burnet, N., Byrne, P., Sokal, M.
Publicado em 1997

Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emitters.

Por Neshasteh-Riz, A., Angerson, W. J., Reeves, J. R., Smith, G., Rampling, R., Mairs, R. J.
Publicado em 1997

A phase II study of oral piritrexim in recurrent high-grade (III, IV) glioma.

Por Bleehen, N. M., Newman, H. V., Rampling, R. P., Ramsay, J. R., Roberts, J. T., Bedford, P., Nethersell, A. B.
Publicado em 1995

Antibody-guided irradiation of malignant pleural and pericardial effusions.

Por Pectasides, D., Stewart, S., Courtenay-Luck, N., Rampling, R., Munro, A. J., Krausz, T., Dhokia, B., Snook, D., Hooker, G., Durbin, H.
Publicado em 1986

Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross...

Por Neshasteh-Riz, A., Mairs, R. J., Angerson, W. J., Stanton, P. D., Reeves, J. R., Rampling, R., Owens, J., Wheldon, T. E.
Publicado em 1998

Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapy.

Por McKie, E. A., MacLean, A. R., Lewis, A. D., Cruickshank, G., Rampling, R., Barnett, S. C., Kennedy, P. G., Brown, S. M.
Publicado em 1996

Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model

Por Mairs, R J, Wideman, C L, Angerson, W J, Whateley, T L, Reza, M S, Reeves, J R, Robertson, L M, Neshasteh-Riz, A, Rampling, R, Owens, J, Allan, D, Graham, D I
Publicado em 2000

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

Por Yung, W K A, Albright, R E, Olson, J, Fredericks, R, Fink, K, Prados, M D, Brada, M, Spence, A, Hohl, R J, Shapiro, W, Glantz, M, Greenberg, H, Selker, R G, Vick, N A, Rampling, R, Friedman, H, Phillips, P, Bruner, J, Yue, N, Osoba, D, Zaknoen, S, Levin, V A
Publicado em 2000